Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optic Neuritis Treatment Trial
NCT00000146Phase 3Unknown
- Sponsor
- National Eye Institute
- Start
- Jul 1988
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in optic neuritis (ON) comparing Oral Prednisone, IV Methylprednisolone and Placebo (3 arms). Primary endpoints: Visual Field at 6 months and Contrast Sensitivity at 6 months. Status: unknown.
02
Drugs
methylprednisoloneprednisone
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on NCT00000146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000146.